TINSETilaknagar Industries Limited· BeveragesCriticalNeutral
Announced Wed, 8 Oct, 2025 · 15:03 IST

CCI clears Tilaknagar's purchase of Pernod Ricard India business

Listed Co AcquisitionStrategic Transactions View source PDFExplain this filing

TI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.3%Reaction day
₹465.90
prior close
₹468.85
announcement price
In-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.3%+0.6% vs market
Breweries & Distilleries peers, median of 24sector-0.4%+0.7% vs sector

On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250 and 0.7 pts more than its Breweries & Distilleries peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.1
10m
+0.1
15m
-0.4
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.3-0.3+0.6-0.4+0.7
Next day
-1.6-0.1-1.5-0.2-1.4
2d
-2.6+0.6-3.2-0.1-2.5
3d
-2.6+0.1-2.7-0.6-2.1
4d
-2.3-1.1-1.2-1.6-0.7
5d
+2.1-0.1+2.2-0.3+2.5
1w
+0.9-0.1+0.9+0.7+0.2
15d
+9.6+2.1+7.6+0.0+9.6
1m
+5.7+0.3+5.3+0.5+5.1
2m
-5.3-6.3+0.9-6.0+0.7
3m
-4.9-4.7-0.2-5.7+0.8
UpDownMarket · Nifty Microcap 250Sector · Breweries & Distilleries peers, median of 24Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

India's competition regulator approved Tilaknagar Industries' proposed acquisition of Pernod Ricard India's beverage business on October 7, 2025. The business produces, bottles, markets and sells alcoholic and other beverages under the Imperial Blue Brands name. Tilaknagar's board approved the deal on July 23, 2025, subject to competition clearance. The transaction value was not disclosed.

Likely market impact

The approval removes a key regulatory hurdle and may support growth, but the deal value, funding and financial benefits are not yet known.